Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia
G Livshits, A Kalinkovich - Ageing Research Reviews, 2024 - Elsevier
Sarcopenia is an age-associated loss of skeletal muscle mass, strength, and function,
accompanied by severe adverse health outcomes, such as falls and fractures, functional …
accompanied by severe adverse health outcomes, such as falls and fractures, functional …
Microbial Synthetic Epigenetic Tools Design and Applications
Microbial synthetic epigenetics offers significant opportunities for the design of synthetic
biology tools by leveraging reversible gene control mechanisms without altering DNA …
biology tools by leveraging reversible gene control mechanisms without altering DNA …
SMYD3 promotes cell cycle progression by inducing cyclin D3 transcription and stabilizing the cyclin D1 protein in medulloblastoma
Simple Summary Medulloblastoma is the most common malignant pediatric brain tumor and
is classified into four molecular subgroups: Wnt, Shh, Group 3, and Group 4. Of these …
is classified into four molecular subgroups: Wnt, Shh, Group 3, and Group 4. Of these …
From cancer big data to treatment: Artificial intelligence in cancer research
Danishuddin, S Khan, JJ Kim - The journal of gene medicine, 2024 - Wiley Online Library
In recent years, developing the idea of “cancer big data” has emerged as a result of the
significant expansion of various fields such as clinical research, genomics, proteomics and …
significant expansion of various fields such as clinical research, genomics, proteomics and …
Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?
Epigenetics is the study of heritable changes in gene expression or function without altering
the DNA sequence. Important factors are part of epigenetic events, such as methylation …
the DNA sequence. Important factors are part of epigenetic events, such as methylation …
An overview regarding pharmacogenomics and biomarkers discovery: focus on breast cancer
TB Scandolara, BR Barreto Pires… - Current Topics in …, 2022 - ingentaconnect.com
Breast cancer represents a health concern worldwide for being the leading cause of cancer-
related women's death. The main challenge for breast cancer treatment involves its …
related women's death. The main challenge for breast cancer treatment involves its …
Promises and challenges in pharmacoepigenetics
Pharmacogenetics, the study of how interindividual genetic differences affect drug response,
does not explain all observed heritable variance in drug response. Epigenetic mechanisms …
does not explain all observed heritable variance in drug response. Epigenetic mechanisms …
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer
SP Nunes, L Morales, C Rubio… - Cell Death …, 2024 - nature.com
Alterations in the epigenetic machinery in both tumor and immune cells contribute to bladder
cancer (BC) development, constituting a promising target as an alternative therapeutic …
cancer (BC) development, constituting a promising target as an alternative therapeutic …
[HTML][HTML] Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer
W Li, H Chen, Z Wang, J Liu, X Lei… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background The Chromobox homolog 4 (CBX4) has been found to be overexpressed in
multiple malignancies. However, the associations between CBX4 and gastric cancer (GC) …
multiple malignancies. However, the associations between CBX4 and gastric cancer (GC) …
Genome-wide analysis of cell-Free DNA methylation profiling with MeDIP-seq identified potential biomarkers for colorectal cancer
X Zhang, T Li, Q Niu, C Qin, M Zhang, G Wu… - World Journal of …, 2022 - Springer
Background Colorectal cancer is the most common malignancy and the third leading cause
of cancer-related death worldwide. This study aimed to identify potential diagnostic …
of cancer-related death worldwide. This study aimed to identify potential diagnostic …